Score Your Stock

LKL LKL INTERNATIONAL BERHAD

0182.KL · Health Care · Health Care Equipment & Services
Bottom 10% of scored stocks
Compare with nearby peers
WeakBottom 10% of scored stocks
Weak SpotRecent Loss

LKL scores 26/100 on fundamentals: in the bottom 10% of 1120 scored Bursa Malaysia stocks. Its strongest area is Risk (50/100); its weakest is Cash & Dividends (0/100). It carries 2 warning flags: Weak Spot, Recent Loss.

Best
Risk 50
Weakest
Cash 0
  • Carries a Weak Spot flag
  • Carries a Recent Loss flag
Mkt capRM 13.6m#1089 of 1113 in BursaEPSRM -0.07P/En/m (loss-making)✓ vs sector avg 26.2×P/B0.1×✓ vs sector avg 1.8×Div yieldNo dividends paidBottom 8% in Bursa52w range · 25% of range0.030.05
as of 18 Oct 2026

Nearby peers

Ranks #29 of 30 in Health Care by score

#1DPHARMA85#26ADVENTA31#27SUPERMX29#28PHARMA27
#29LKL26
#30CAREPLS22

One-Minute Summary

Why LKL scores 26

A financially stretched, expensively priced stock, but cash & dividends needs attention.

What looks good
What to watch

After Jun '26 results: 20 → 20See all movers →

Business Strength

10
Why 10?
Pillar score: (0 + 1 + 0 + 0 + 0) = 1 of 10 points → 10
Return on Equity (ROE)-22%Weak4-Year Revenue Growth+6%/yrOkay4-Year Profit Growthn/m (loss-making)WeakNet Profit Marginn/m (loss-making)WeakQuarterly Momentumn/m (loss-making)Weak
Show 3 charts

Net Profit & Equity, with ROE

Net Profit ↓ -207.1%Equity ↓ -43.1%ROE % -22%
Net ProfitEquityROE %
-7m-41m-26m-21m172m130m105m98m202320242025TTM-4.1%-31.7%-25.2%-22%

Revenue & Net Profit, with Net Margin

Revenue ↑ +17.5%Net Profit ↓ -207.1%Net Margin % -41%
RevenueNet ProfitNet Margin %
45m48m57m52m-7m-41m-26m-21m202320242025TTM-15.7%-86.8%-46.9%-41%

Sales grew about 17.5% over 4 years: customers keep spending more with this company.

The company lost money in recent years: the bars below zero are losses, not profits.

Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)

Revenue ↓ -8.9%Net Profit ↑ +59.5%Net Margin % -31.4%
RevenueNet ProfitNet Margin %
11m17m12m10m12m23m8m10m-8m-20m-3m-10m2m-17m-4m-3mSep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26-70.5%-118.1%-23.9%-95.1%18%-76%-56.6%-31.4%
▼▼▼▼▲▼▼▼

Sales fell about 8.9% over the last 8 quarters: worth watching why.

The company made a loss in at least one of the last 8 quarters: the bars below zero are losses, not profits.

Why 33?
Pillar score: (2 + 0 + 0) = 2 of 6 points → 33
Debt-to-Equity0.5×StrongCurrent Ratio0.9×WeakInterest Coverage-9.3×Weak
Show 2 charts

Debt vs Equity, with D/E ratio

Total Debt ↑ +53.4%Equity ↓ -43.1%D/E 0.5×
Total DebtEquityD/E
32m54m50m49m172m130m105m98m202320242025TTM0.2×0.4×0.5×0.5×

Borrowings grew about 53.4% over 4 years: watch this; rising debt adds pressure in bad times.

Short-term assets vs bills, with Current Ratio

Current Assets ↓ -65.5%Current Liabilities ↓ -9.1%Current Ratio 0.9×
Current AssetsCurrent LiabilitiesCurrent Ratio
99m84m41m34m42m60m37m38m202320242025TTM2.4×1.4×1.1×0.9×
Why 0?
Pillar score: (0 + 0 + 0 + 0) = 0 of 8 points → 0
Dividend QualityNo dividends paidWeak
Payout ratio: -0%
Operating Cash FlowNegative recentlyWeakFree Cash FlowNegative recentlyWeakCash & Cash EquivalentsShrinking & thinWeak
Show 3 charts

Operating vs Free Cash Flow

Operating CF ↓ -50.3%Free CF ↑ +92.2%
Operating CFFree CF
-16m-17m-1m-24m-42m-35m-4m-3m202320242025TTM

Cash flow has been weak or negative recently: the business is burning cash, not building it.

Cash vs Total Debt

Cash ↓ -5.5%Short-Term Debt ↑ +3.1%Total Debt ↑ +53.4%
CashShort-Term DebtTotal Debt
11m4m15m10m29m51m30m30m32m54m50m49m202320242025TTM

Dividends per Share, with Yield

DPS (sen) → +0%Yield % 0%
DPS (sen)Yield %
000020222023202420250%0%0%0%

Dividends per share have been maintained or raised: management shares the rewards with you.

Why 33?
Pillar score: (0 + 2 + 0) = 2 of 6 points → 33
P/E Ration/m (loss-making)WeakP/B Ratio0.1×StrongPEG Ration/m (growth not measurable)Weak
Show chart

Score vs Share Price

Score (0-100)Share price
RM 0.04RM 0.04RM 0.03100500Oct '25Feb '26Jun '26Oct '26

The share price is down about 12.5% over the past year.

What happened, and how the price moved

Nothing to show for this period. Try a longer range or another filter.

Why 50?
Pillar score: (0 + 0 + 2 + 2 + 2 + 0) = 6 of 12 points → 50
Earnings ConsistencyVery bumpyWeakDebt Trend (4yr)RisingWeakShare Count Trend (4yr)+0%/yrStrongInventory vs Sales (4yr)-15.9 pp/yr vs salesStrongAsset Turnover Trend (4yr)+64.6%StrongQuarterly ConsistencyLoss in 7 of 8 quartersWeak
Show chart

Revenue vs Inventory, with Inventory % of Revenue

Revenue ↑ +17.5%Inventory ↓ -28.3%Inv. % of Rev. 22.7%
RevenueInventoryInv. % of Rev.
45m48m57m52m17m18m13m12m202320242025TTM37.2%37.2%22.8%22.7%

Get an email when LKL's score changes, and why

Own more than one stock? Check them all at once ›
Ranks #29 of 30 in Health Care by score

Sector peers

#1DPHARMA85#26ADVENTA31#27SUPERMX29#28PHARMA27
#29LKL (you)26
#30CAREPLS22

Full Financial History

Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.

Financial YearRevenueNet ProfitOperating Cash FlowFree Cash FlowCapExCashTotal DebtShort-Term DebtEquityCurrent AssetsCurrent LiabilitiesTotal AssetsTotal LiabilitiesInventoryDividendsReturn on Equity (ROE)Net Profit MarginDebt-to-EquityCurrent RatioInterest CoverageDiv yieldP/E RatioP/B Ratio
2026RM 52.4mRM -21.5mRM -24.2mRM -3.3mRM 20.9mRM 10.4mRM 49.1mRM 29.6mRM 97.7mRM 34.2mRM 38.1mRM 153.5mRM 56.5mRM 11.9m--22%-41%0.5×0.9×-9.3×---
2025RM 56.5mRM -26.5mRM -1.3mRM -4.5mRM -3.2mRM 14.8mRM 49.9mRM 30.1mRM 105.3mRM 40.9mRM 37.2mRM 160.8mRM 56.2mRM 12.9mRM 0.0m-25%-47%0.5×1.1×-9.9×0%-0.5×0.1×
2024RM 47.6mRM -41.3mRM -17.2mRM -35.5mRM -18.3mRM 4.4mRM 53.7mRM 50.6mRM 130.4mRM 83.9mRM 59.9mRM 191.5mRM 61.8mRM 17.7mRM 0.0m-32%-87%0.4×1.4×-24.3×0%-1.0×0.3×
2023RM 44.6mRM -7.0mRM -16.1mRM -42.1mRM -26.0mRM 11.0mRM 32.0mRM 28.7mRM 171.7mRM 99.1mRM 41.9mRM 215.0mRM 43.9mRM 16.6mRM 0.0m-4%-16%0.2×2.4×-3.2×0%-8.1×0.3×